Manhattan Scientifics Operating Margin 2010-2024 | MHTX
Current and historical operating margin for Manhattan Scientifics (MHTX) over the last 10 years. The current operating profit margin for Manhattan Scientifics as of June 30, 2024 is 0.00%.
Manhattan Scientifics Operating Margin Historical Data |
Date |
TTM Revenue |
TTM Operating Income |
Operating Margin |
2020-06-30 |
$0.00B |
0 |
0.00% |
2017-12-31 |
$0.00B |
$0.00B |
0.00% |
2017-09-30 |
$0.00B |
$0.00B |
0.00% |
2017-06-30 |
$0.00B |
$-0.01B |
0.00% |
2017-03-31 |
$0.00B |
$-0.01B |
0.00% |
2016-09-30 |
$0.00B |
$-0.01B |
0.00% |
2015-12-31 |
$0.00B |
$-0.01B |
0.00% |
2015-06-30 |
$0.00B |
$-0.01B |
0.00% |
2015-03-31 |
$0.00B |
$0.00B |
0.00% |
2014-12-31 |
$0.00B |
$0.00B |
0.00% |
2014-06-30 |
$0.00B |
$0.00B |
0.00% |
2014-03-31 |
$0.00B |
$0.00B |
0.00% |
2013-09-30 |
$0.00B |
$0.00B |
0.00% |
2013-06-30 |
$0.00B |
$0.00B |
0.00% |
2013-03-31 |
$0.00B |
0 |
0.00% |
2012-12-31 |
$0.00B |
0 |
0.00% |
2012-09-30 |
$0.00B |
0 |
0.00% |
2012-06-30 |
$0.00B |
$0.00B |
0.00% |
2012-03-31 |
$0.00B |
$0.00B |
0.00% |
2011-12-31 |
$0.00B |
$0.00B |
0.00% |
2011-09-30 |
$0.00B |
0 |
0.00% |
2011-06-30 |
$0.00B |
$0.00B |
100.00% |
2011-03-31 |
$0.00B |
$0.00B |
100.00% |
2010-12-31 |
$0.00B |
$0.00B |
100.00% |
2010-09-30 |
$0.00B |
0 |
0.00% |
2010-06-30 |
$0.00B |
0 |
0.00% |
2010-03-31 |
$0.00B |
0 |
0.00% |
Sector |
Industry |
Market Cap |
Revenue |
Computer and Technology |
Nanotechnology Equipment and Services |
$0.000B |
$0.000B |
Manhattan Scientifics Inc. is a technology solutions provider that focuses on the nanomedicine space. The Company acts as a technology incubator that acquires, develops and commercializes life-enhancing technologies in various fields, with emphasis in the areas of alternative energy, and consumer and commercial electronics. Manhattan has three wholly owned subsidiaries of which Metallicum is the only operating subsidiary; and Tamarack and Teneo are dormant. Metallicum is a nanotechnology start-up company that focuses on the development and manufacture of nanostructured metals for medical implants and other applications. Metallicum's initial products include nanostructured bulk metals and alloys in the form of rod, bar, wire and foil. Manhattan Scientifics Inc. conducts its operations primarily in the United States and has its offices in New Mexico, New York and Montreal.
|